Burlibact S 1000mg/500mg Injection
Marketer
Unibiotech Formulations
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Burlibact S 1000mg/500mg Injection
Combiflox 1000mg/500mg Injection, a dual-action antibiotic, combats diverse bacterial infections. Administered only by a healthcare provider, this medication inhibits microbial proliferation and infection spread. Complete the prescribed dosage; premature cessation may compromise efficacy. Regular appointments are crucial. Common side effects include nausea, vomiting, diarrhea, and dyspepsia; consult your doctor if these worsen. Seek immediate medical attention for allergic reactions (rash, itching, swelling, respiratory distress). Inform your physician of all other medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally safe for driving, refrain if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and hydration promote quicker recovery. Your doctor may order lab tests to monitor treatment effectiveness.
Uses of Burlibact S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Burlibact S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Burlibact S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Burlibact S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Burlibact S 1000mg/500mg Injection works:
Ceftriaxone 1000mg/Sulbactam 500mg injection, marketed as Burlibact S, combines a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering bacterial survival. Sulbactam counteracts bacterial resistance mechanisms, thereby improving Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Burlibact S 1000mg/500mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Burlibact S (1000mg/500mg) is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human studies are scarce.
Breast feedingCAUTION
The administration of Burlibact S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Burlibact S 1000mg/500mg Injection could reduce vigilance, impair vision, and induce drowsiness or dizziness. Refrain from driving if such effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Burlibact S 1000mg/500mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication Burlibact S (1000mg/500mg) requires careful administration in individuals with advanced hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage changes for Burlibact S (1000mg/500mg) injection are not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Burlibact S 1000mg/500mg Injection :
Omit a scheduled Burlibact S 1000mg/500mg Injection? Seek your physician's advice.
Facts to Know About Burlibact S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently